BTIG Downgrades Akoya Biosciences Inc (AKYA) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Akoya Biosciences Reports Second Quarter 2024 Financial Results
August 5, 2024 4:00 PM EDTMARLBOROUGH, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (Akoya), The Spatial Biology Company®, today announced its financial results for the second quarter ending June 30, 2024.
Our second-quarter revenue showed a strong rebound with 26% sequential top-line growth and a stable year-over-year performance, said Brian McKelligon, CEO of Akoya Biosciences. We believe that Akoyas platforms are poised to lead the spatial biology market from... More



